every incremental ₹1 cr spent in capex, generates 4x revenue: rossari biotech | cnbc tv18
Published 2 months ago • 1.3K plays • Length 7:14Download video MP4
Download video MP3
Similar videos
-
8:31
had the highest-ever ebitda at ₹250 cr and the co is at zero-debt position today: rossari biotech
-
8:11
rossari biotech reports mixed set of q4 earnings | co-founder sunil chari on this & more | cnbc-tv18
-
6:54
hppc segment growth was led by a surge in volume: rossari biotech | cnbc tv18
-
6:08
seeing strong demand in domestic & export markets: rossari biotech | cnbc tv18
-
6:11
rossari biotech's sunil chari exclusive on the firm's mixed q3fy23 results | midcap radar
-
58:18
rossari biotech ltd q4 fy2023-24 earnings conference call
-
22:05
fundamental concepts of faradic non faradic electrochemical process
-
16:09
nota lengkap bab 1, sains tingkatan 1 - pengenalan kepada penyiasatan saintifik
-
9:23
rossari biotech - highest net profit | how to trade after results? | financewithpranav
-
5:52
fy24 ebitda growth would be higher than revenue growth: rossari biotech | cnbc tv18
-
1:16
momentumisers : tracking the stock movement of rossari biotech | bazaar open exchange | cnbc-tv18
-
8:29
sunil chari discusses rossari biotech's textile business, exports outlook | midcap radar | cnbc-tv18
-
7:33
hppc segment has seen 15% uptick in volume but decline in pricing: rossari biotech | cnbc tv18
-
15:14
can this specialty chemical company give multibagger returns? rossari biotech fundamental analysis